News and reflections from the world of AI

    Aiforia Hub for Education: Interview with a Professor of Veterinary Pathology

    Knowledge of histology is necessary for a strong understanding of human biology particularly in pathology specializations. Medical schools typically ...
    Written by Aiforia

    New Finnish consortium aims to enhance diagnostics and combat pandemics

    The COVID-19 pandemic has highlighted the importance of efficient diagnostic methods. Beyond battling pandemics, there are also significant ...
    Written by Aiforia

    Interview with Dr. Talat Zehra: digital pathology & AI in Pakistan

    Tell us a bit about yourself. I have been working in a medical university for the last five years and teach pathology to students in medicine and ...
    Written by Aiforia
    March 26, 2021

    Benefits of AI and digital pathology to the clinical lab: interview with pathologists Dr. Mirtti and Dr. Sandeman

    Pathologists have been examining glass slides under a microscope for over 150 years. Only recently did laboratories around the world start digitizing their slides, enabling more efficient workflows and increased accuracy in diagnostics. Adding AI to the newly digitized practice has the potential to increase these benefits exponentially. In this interview pathologists from Sweden and Finland share ...
    Written by Aiforia
    March 22, 2021

    Interview with Dr. Marika Kangasniemi: AI in endometrial cell analysis

    Introduction PEDEGO, a research unit at the University of Oulu, covers a wide range of topics primarily around pediatrics, obstetrics, and gynecology. The metabolic health group within this unit has several ongoing clinical trials related to reproductive and metabolic health in women, including the function of the endometrium in women with polycystic ovary syndrome (PCOS). PCOS affects 10-18% of ...
    Written by Aiforia
    March 16, 2021

    Validation of PD-L1 AI model launches in six labs across the Netherlands

    Introduction  Programmed death-ligand 1 (PDL1) is a protein that, when attached to T cells, prevent the immune system from killing cancer cells. Hence, PDL1 is used as a biomarker for tumor immune escape, a sign of increasing cancer progression. PDL1 percentage is also a significant predictor for immunotherapy efficacy, whereby immune checkpoint inhibitors bind to PDL1 and block its ability to ...
    Written by Aiforia
    1 2 3 4 5